Special Issue "Layered Double Hydroxide Used in Drug Delivery"

Quicklinks

A special issue of Pharmaceutics (ISSN 1999-4923).

Deadline for manuscript submissions: closed (23 May 2014)

Special Issue Editors

Guest Editor
Prof. Dr. Dermot O’Hare
Chemistry Research Laboratory, Department of Chemistry, University of Oxford, Oxford, OX13TA, UK
Website: http://research.chem.ox.ac.uk/dermot-ohare.aspx
E-Mail: dermot.ohare@chem.ox.ac.uk
Interests: layered double hydroxides; intercalation; in-situ diffraction; materials; organometallic; catalysis

Guest Editor
Dr. Gareth R. Williams
UCL School of Pharmacy, University College London, 29 - 39 Brunswick Square, London WC1N 1AX, UK
Website: http://iris.ucl.ac.uk/iris/browse/profile?upi=GWILL02
E-Mail: g.williams@ucl.ac.uk
Phone: +44 207 753 5868
Fax: +44 207 753 5942
Interests: drug delivery; formulation; electrospinning; layered metal hydroxides; adjuvants

Special Issue Information

Dear Colleague,

The anion exchange capability of layered double hydroxides (LDHs), coupled with the ability of many active pharmaceutical ingredients (APIs) to form anions, has resulted in an explosion of interest in using LDHs for drug delivery applications. A search in Google Scholar for “layered double hydroxides AND drug delivery” results in some 21,500 hits, clearly demonstrating the research effort underway in this area. The Special Issue of Pharmaceutics on “Layered double hydroxides in drug delivery” will address all areas of pharmaceutics where LDHs have been explored, from their use as controlled or targeted release formulations (either alone or in combination with other excipients) through to their applications in DNA or RNA delivery on the sub-cellular level. Original research papers or review articles on any of these aspects are welcomed for this Special Issue.

Prof. Dr. Dermot O’Hare
Dr. Gareth R. Williams
Guest Editors

Submission

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. Papers will be published continuously (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are refereed through a peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed Open Access quarterly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 500 CHF (Swiss Francs). English correction and/or formatting fees of 250 CHF (Swiss Francs) will be charged in certain cases for those articles accepted for publication that require extensive additional formatting and/or English corrections.

Keywords

  • layered double hydroxide
  • drug delivery
  • gene delivery
  • controlled release
  • targeted release
  • sustained release

Published Papers (2 papers)

by ,  and
Pharmaceutics 2014, 6(2), 298-332; doi:10.3390/pharmaceutics6020298
Received: 11 April 2014; in revised form: 15 May 2014 / Accepted: 20 May 2014 / Published: 17 June 2014
Show/Hide Abstract | PDF Full-text (2325 KB) | HTML Full-text | XML Full-text
abstract graphic

by , ,  and
Pharmaceutics 2014, 6(2), 235-248; doi:10.3390/pharmaceutics6020235
Received: 3 April 2014; in revised form: 8 May 2014 / Accepted: 9 May 2014 / Published: 22 May 2014
Show/Hide Abstract | PDF Full-text (926 KB) | HTML Full-text | XML Full-text | Supplementary Files
abstract graphic

Last update: 2 April 2014

Pharmaceutics EISSN 1999-4923 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert